ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)
$24.23 -0.19 (-0.7781%)
Analysed ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) News Sources
Adaptive Biotechnologies (ADPT) Upgraded to Buy: What Does It Mean for the Stock?
21-07-2026
yahoo.com
Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
22-07-2026
yahoo.com
Will Earnings Estimate Upgrades and a Smaller Projected Loss Change Adaptive Biotechnologies' (ADPT) Narrative?
23-07-2026
yahoo.com
Adaptive Biotechnologies (ADPT) Stock May Be 22% Undervalued As Growth Hopes Build
24-07-2026
yahoo.com
Adaptive Biotechnologies (ADPT) After Loss Forecasts Improve Is The Rally Already Priced In
24-07-2026
yahoo.com
Adaptive Biotechnologies Q2 Earnings Call Highlights
29-07-2026
marketbeat.com
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates
29-07-2026
yahoo.com
Adaptive Biotechnologies (ADPT) Reports Q2 Earnings: What Key Metrics Have to Say
29-07-2026
yahoo.com
Adaptive Biotechnologies Corp (ADPT) (Q2 2026) Earnings Call Highlights: MRD Revenue Surges ...
30-07-2026
yahoo.com
Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next.
21-08-2026
barchart.com
What is the current price of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)?
The current price of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) is $24.23.
ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) absolute price change since previous trading day?
The absolute price change of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) since the previous trading day is $-0.19.
ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) percentage price change since previous trading day?
The percentage price change of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) since the previous trading day is -0.7781%.
What is the most recent average sentiment score for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)?
The most recent average sentiment score for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)?
The most recent sentiment for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) is .
SEC-8K** Filing Available For ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.